USCAP 2024: Validation and clinical implementation of an Artificial Intelligence solution for assisting diagnosis of microcalcifications in breast biopsies

Back

This study, conducted at the Ohio State University Wexner Medical Center, showed high accuracy for Ibex’s Galen Breast in the detection of microcalcifications and lobular neoplasia in breast biopsies, the detection of which is often tedious and time-consuming. The AI solution showcased an impressive sensitivity rate, positioning it as a promising screening tool, potentially leading to enhanced efficiency and reduced turnaround time for detecting microcalcifications.

Back

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.
Articles

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

Articles

How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News

Videos

The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics